Skip to main content
. 2021 Dec 15;12:780145. doi: 10.3389/fimmu.2021.780145

Figure 3.

Figure 3

Choice of either autologous or allogeneic CAR-T cell therapy. *Standard lymphodepletion—conditioning regimen in which intermediate doses of chemotherapy drugs are applied. **Enhanced lymphodepletion—conditioning regimen in which high doses of chemotherapy drugs and/or additional biologic medications (monoclonal antibody, including allo-647) are applied.